Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behavioral effects that suggest antinociception in rats

Anesthesia and Analgesia

Volumn 85, Issue 3, 1997, Pages 627-632

  Sjölund, Karl Fredrik ^a,b   Sollevi, Alf ^a   Segerdahl, Märta ^a   Lundeberg, Thomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; SUBSTANCE P;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CALCIUM CURRENT; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HYPERALGESIA; IMMUNOREACTIVITY; INTRATHECAL DRUG ADMINISTRATION; NONHUMAN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SYNAPTIC TRANSMISSION;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANALGESIA; ANIMALS; BEHAVIOR, ANIMAL; CALCITONIN GENE-RELATED PEPTIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, SPINAL; MALE; MOTOR ACTIVITY; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, PURINERGIC P1; SUBSTANCE P; THEOPHYLLINE;

EID: 0342617771     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199709000-00025     Document Type: Article

References (28)

1. Segerdahl M, Ekblom A, Sandelin K, et al. Peroperative adenosine infusion reduces the requirements for isoflurane and postoperative analgesics. Anesth Analg 1995;80:1145-9.
2. Segerdahl M, Ekblom A, Sjölund K-F, et al. Systemic adenosine attenuates touch evoked allodynia induced by mustard oil in humans. Neuroreport 1995;6:753-6.
3. Belfrage M, Sollevi A, Segerdahl M, et al. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth Analg 1995; 81:713-7.
4. 1-selective adenosine agonist abolishes allodynia elicited by vibration and touch after intrathecal injection. Anesth Analg 1995;80:844-7.
5. Sawynok J, Sweeney MI. The role of purines in nociception. Neuroscience 1989;32:557-69.
6. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988;33:87-107.
7. Sjölund K-F, Sollevi A, Segerdahl M, et al. Intrathecal and systemic R-phenylisopropyladenosine reduces scratching behaviour in a rat mononeuropathy model. Neuroreport 1996;7: 1856-60.
8. Cui DIG, Sollevi A, Linderoth B, Meyerson BA. Adenosine receptor activation suppresses tactile hypersensitivity and potentiates spinal cord stimulation in mononeuropathic rats. Neurosci Lett. In press.
9. Poon A, Sawynok J. Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration. Eur J Pharmacol 1995;286:177-84.
10. Li J, Perl ER. Adenosine inhibition of synaptic transmission in the substantia gelatinosa. J Physiol 1994;72:1611-21.
11. Salter MW, De Koninck Y, Henry JL. Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn. Prog Neurobiol 1993;41:125-56.
12. De Koninck Y, Salter MW, Henry LH. Substance P released endogenously by high-intensity sensory stimulation potentiates purinergic inhibition of nociceptive dorsal horn neurons induced by peripheral vibration. Neurosci Lett 1994;176:128-32.
13. Stiller CO, Fastbom J, Fredholm BB, Brodin E. The adenosine analogue R-PIA interacts with substance P binding in rat brain and spinal cord. Acta Physiol Scand 1991;141:573-74.
14. Santicioli P, Del Bianco E, Tramontana M, Maggi CA. Adenosine inhibits action potential-dependent release of calcitonin gene-related peptide- and substance P-like immunoreactivities from primary afferents in rat spinal cord. Neurosci Lett 1992; 144:211-4.
15. Dickenson AH. Spinal cord pharmacology of pain. Br J Anaesth 1995;75:193-200.
16. Schaible HG, Hope PJ, Lang CW, Duggan AW. Calcitonin gene-related peptide causes intraspinal spreading of substance P released by peripheral stimulation. Eur J Neurosci 1992;4:750-7.
17. Yaksh TL, Rudy TA. Analgesia mediated by a direct spinal action of narcotics. Science 1976;192:1357-8.
18. 8-37. Brain Res 1995;698:23-9.
19. Brodin E, Lindefors N, Dalsgaard CJ, et al. Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A. Regul Pept 1986;13:253-72.
20. Bileviciute I, Lundeberg T, Ekblom A, Theodorsson E. Substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity (-LI) in rat knee joint synovial fluid during acute monoarthritis is not correlated with concentrations of neuropeptide-LI in cerebrospinal fluid and plasma. Neurosci Lett 1994;167:145-8.
21. Woolf CJ, Mitchell D, Barrett GD. Antinociceptive effect of peripheral segmental stimulation in the rat. Pain 1980;8:237-52.
22. Karlsten R, Gordh T, Hartvig P, Post C. Effects of intrathecal injection of the adenosine receptor agonist R-phenylisopropyl-adenosine and N-ethylcarboxamide-adenosine on nociception and motor function in the rat. Anesth Analg 1990;71:60-4.
23. Paalzow GHM. Noradrenaline but not dopamine involved in NMDA receptor-mediated hyperalgesia induced by theophylline in awake rats. Eur J Pharmacol 1994;252:87-97.
24. Iversen LL. Central actions of substance P and related tachykinins. J Psychopharmacol 1989;3:1-6.
25. Vasko MR, Ono H. Adenosine analogs do not inhibit the potassium-stimulated release of substance P from rat spinal cord slices. Naunyn Schmiedebergs Arch Pharmacol 1990;342: 441-6.
26. Yaksh TL, Michener SR, Bailey JE, et al. Survey of distribution of substance P, vasoactive intestinal polypeptide, cholecystokinin, neurotensin, Met-enkephalin, bombesin and PHI in the spinal cord of the cat, dog, sloth and monkey. Peptides 1988;9:357-72.
27. Traub RJ. The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat. Pain 1996;67:151-61.
28. Malcangio M, Bowery NG. Calcitonin gene-related peptide content, basal outflow and electrically-evoked release from monoarthritic rat spinal cord in vitro. Pain 1996;66:351-8.